• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于传染病的抗炎药物的研发。

The development of anti-inflammatory drugs for infectious diseases.

作者信息

Garcia Cristiana Couto, Guabiraba Rodrigo, Soriani Frederico Marianetti, Teixeira Mauro Martins

机构信息

Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.

出版信息

Discov Med. 2010 Dec;10(55):479-88.

PMID:21189219
Abstract

Traditionally, disease is thought to result from an insufficient response of the host to infection, leading to increased replication of microorganisms and consequently disease. However, infection may not necessarily lead to disease and disease is not only the result of uncontrolled replication of a microorganism. Indeed, the inflammatory response triggered by certain infections is frequently the cause of tissue damage and death. The present review argues that it is possible to separate mechanisms necessary for the host response to deal with infection from those which cause unwanted inflammation and drive disease. By understanding mechanisms which drive disease and where/how interaction leads to disease, we may be able to devise novel therapies to alleviate suffering of patients. Below, we will describe three situations--influenza, dengue and sepsis--in which unwanted (excessive, misplaced or altered) inflammation is responsible for disease induction. In these three situations, we will also describe some examples of molecules which have been found to drive disease but appear not to be essential for the ability of the host to control infection.

摘要

传统上,疾病被认为是宿主对感染反应不足导致的,从而导致微生物复制增加,进而引发疾病。然而,感染不一定会导致疾病,疾病也不仅仅是微生物不受控制复制的结果。事实上,某些感染引发的炎症反应常常是组织损伤和死亡的原因。本综述认为,有可能将宿主应对感染所需的机制与那些导致不必要炎症并引发疾病的机制区分开来。通过了解引发疾病的机制以及相互作用在何处/如何导致疾病,我们或许能够设计出新颖的疗法来减轻患者的痛苦。下面,我们将描述三种情况——流感、登革热和败血症——在这些情况中,不必要的(过度、错位或改变的)炎症是疾病诱发的原因。在这三种情况中,我们还将描述一些已被发现会引发疾病但似乎对宿主控制感染的能力并非必不可少的分子实例。

相似文献

1
The development of anti-inflammatory drugs for infectious diseases.用于传染病的抗炎药物的研发。
Discov Med. 2010 Dec;10(55):479-88.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals.病原体、组织损伤和继发性炎症信号对树突状细胞抗原呈递的调节作用。
Curr Opin Pharmacol. 2014 Aug;17:64-70. doi: 10.1016/j.coph.2014.07.013. Epub 2014 Aug 13.
4
Role of lipoxin in the modulation of immune response during infection.脂氧素在感染期间免疫反应调节中的作用。
Int Immunopharmacol. 2008 Oct;8(10):1316-9. doi: 10.1016/j.intimp.2008.01.001. Epub 2008 Jan 18.
5
Molecular biological assessment methods and understanding the course of the HIV infection.分子生物学评估方法与对HIV感染病程的理解
APMIS Suppl. 2003(114):1-37.
6
Influenza ("Bird Flu"), inflammation and anti-inflammatory/analgesic drugs.流感(“禽流感”)、炎症与抗炎/镇痛药。
Inflammopharmacology. 2006 Mar;14(1-2):2-9. doi: 10.1007/s10787-006-0002-5.
7
Apoptotic cell death in the pathogenesis of infectious diseases.凋亡性细胞死亡在传染病发病机制中的作用
J Infect. 2001 May;42(4):227-34. doi: 10.1053/jinf.2001.0836.
8
Anti-inflammatory drugs and atherosclerosis.抗炎药物与动脉粥样硬化
Curr Opin Lipidol. 2007 Dec;18(6):638-44. doi: 10.1097/MOL.0b013e3282f0ee11.
9
Modulation of the host inflammatory response in periodontal disease management: exciting new directions.调控牙周病治疗中的宿主炎症反应:激动人心的新方向。
Int Dent J. 2009 Oct;59(5):305-8.
10
Host factors affecting disease transmission.影响疾病传播的宿主因素。
Dent Clin North Am. 1996 Apr;40(2):263-75.

引用本文的文献

1
The Multifaceted Role of Annexin A1 in Viral Infections. annexin A1 在病毒感染中的多效性作用
Cells. 2023 Apr 11;12(8):1131. doi: 10.3390/cells12081131.
2
Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing.针对药物再利用,对 MTB 单感染、HIV 单感染和 MTB/HIV 共感染中的差异表达网络进行系统比较。
PLoS Comput Biol. 2022 Dec 19;18(12):e1010744. doi: 10.1371/journal.pcbi.1010744. eCollection 2022 Dec.
3
Effect of Spore-Forming Probiotics on the Poultry Production: A Review.
产孢益生菌对家禽生产的影响:综述
Food Sci Anim Resour. 2022 Nov;42(6):968-980. doi: 10.5851/kosfa.2022.e41. Epub 2022 Nov 1.
4
Annexin A1-FPR2/ALX Signaling Axis Regulates Acute Inflammation during Chikungunya Virus Infection. annexin A1-FPR2/ALX 信号轴调节寨卡病毒感染期间的急性炎症。
Cells. 2022 Aug 31;11(17):2717. doi: 10.3390/cells11172717.
5
Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.转录组网络分析表明,免疫调节药物可合理用于 COVID-19 治疗。
Genomics. 2021 Mar;113(2):564-575. doi: 10.1016/j.ygeno.2020.12.041. Epub 2021 Jan 20.
6
Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?利用炎症解决为基础的治疗药物治疗肺部病毒感染:新冠病毒感染能带来什么未来?
Br J Pharmacol. 2020 Sep;177(17):3898-3904. doi: 10.1111/bph.15164. Epub 2020 Jul 8.
7
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
8
Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damage.TLR9 和 PI3Kγ 信号的汇聚诱导无菌性炎症和器官损伤。
Sci Rep. 2019 Dec 13;9(1):19085. doi: 10.1038/s41598-019-55504-0.
9
Host⁻Microbe Interactions and Gut Health in Poultry-Focus on Innate Responses.家禽宿主与微生物的相互作用及肠道健康——聚焦先天免疫反应
Microorganisms. 2019 May 16;7(5):139. doi: 10.3390/microorganisms7050139.
10
Aspirin use and long-term rates of sepsis: A population-based cohort study.阿司匹林的使用与脓毒症的长期发生率:一项基于人群的队列研究。
PLoS One. 2018 Apr 18;13(4):e0194829. doi: 10.1371/journal.pone.0194829. eCollection 2018.